ACTIBLOK AM
Product Description
Biocon Limited
-
IN -
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product STATIX? EZ
Biocon offers a wide range of metabolic which includes statix ez. Composition: atorvastatin 10mg + ezetimibe 10mg tablets. Mechanism of action: atorvastatin: atorvastatin belongs to the category of statins, which inhibit 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase, fenofibrate: fenofibrate ac... -
Product STATIX? F
Biocon offers a wide range of metabolic which includes statix f. Composition: atorvastatin 10mg + fenofibrate (micronised) 200mg tablets. Mechanism of action: atorvastatin: atorvastatin belongs to the category of statins, which inhibit 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase, fenofibrate:... -
Product ACTIBLOK-IPR
Biocon offers a wide range of metabolic which includes actiblok-ipr. Composition: metoprolol extended release 25/50/100mg tablets. Mechanism of action: metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. It competitively antagonizes catecholamines at peripheral (especiall... -
Product Advacan
Biocon offers a wide range of nephrology which includes advacan. Composition: each uncoated /coated tablet contains everolimus 0.5mg and 0.25mg. Mechanism of action: everolimus, a proliferation signal inhibitor, prevents allograft rejection in allotransplantation. It exerts its immunosuppressive effect by ... -
Product ALZUMAb
Biocon offers a wide range of immunotherapy which includes alzumab?. Composition: each vial contains 25 mg of itolizumab. Itolizumab is a humanized recombinant anti-cd-6 monoclonal antibody. Each ml contains 5 mg of itolizumab for intravenous use. Mechanism of action: itolizumab is a humanized recombinant ... -
Product Atsure?
Biocon offers a wide range of oncotherapeutic which includes atsure. Composition: gemcitabine hydrochloride usp equivalent to gemcitabine 200mg/1gm/1.4gm. Mechanism of action: emcitabine exhibits cell phase specificity, primarily killing cells undergoing dna synthesis (s-phase) and also blocking the progre... -
Product BASALOG Refil ?
Biocon offers a wide range of metabolic which includes basalog refil ?. Composition: each ml contains insulin glargine (rdna origin) 100 iu. In-use stability: 28 days/4 weeks. Mechanism of action: insulin glargine has low aqueous solubility at neutral ph. At ph 4, as in the glargine injection solution, it ... -
Product BASALOG?
Biocon offers a wide range of metabolic which includes basalog. Composition: insulin glargine (rdna origin) 100 iu. Benzyl alcohol, 1% w/v (as preservative). Mechanism of action: insulin glargine has low aqueous solubility at neutral ph. At ph 4, as in the glargine injection solution, it is completely solu...
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance